Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CYSB2500176	冻干静注乙型肝炎人免疫球蛋白		Injection	Biological Products	Supplementary Application	2025-08-06		Chengdu Rongsheng Pharmaceuticals Co Ltd			view
CXSB2100004	冻干静注乙型肝炎人免疫球蛋白（pH4）	human hepatitis B immunoglobulin(pH4)	Lyophilized	Biological Products	Supplementary Application	2021-01-11	成都蓉生药业有限责任公司	Chengdu Rongsheng Pharmaceuticals Co Ltd	Certificate Issued	2021-10-08	view
CXSS1900045	冻干静注乙型肝炎人免疫球蛋白（pH4）	human hepatitis B immunoglobulin(pH4)	Lyophilized	Biological Products(15)	New Drug Application	2019-12-11	同路生物制药有限公司	Tonrol Bio-Pharmaceutical Co Limited	Certificate Issued	2021-08-04	view
CXSL1100046	冻干静注乙型肝炎人免疫球蛋白(pH4)	human hepatitis B immunoglobulin(pH4)	Lyophilized	Biological Products(15)	New Drug Application	2011-09-21	同路生物制药股份有限公司	Tonrol Bio-Pharmaceutical Co Limited	Certificate Issued	2013-04-11	view